Verastem reported $0 in Stock for its fiscal quarter ending in March of 2022.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
Cytokinetics USD 807K 427K Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
Incyte USD 134.25M 21.71M Sep/2026
Laboratory Of America USD 538.4M 23.8M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 194.32M 46.35M Sep/2026